INHSU 2016 Holly Hagan of New York University presenting at INHSU 2016. Photo by Liz Highleyman, hivandhepatitis.comINHSU 2016INHSU opens with focus on HCV prevention & treatment for people who inject drugs. Professor Andrea Cox of Johns Hopkins University presenting at INHSU 2016. Photo by Liz Highleyman, hivandhepatitis.comHCV vaccineHepatitis C vaccine development shows progress but scientific barriers remain. Photo of treatment prioritisation debate including Sharon Hutchinson, Anne Øvrehus, Peer Brehm Christensen, Graham Foster, and Martin Kåberg. Photo by Liz Highleyman, hivandhepatitis.comTreatment as preventionHCV treatment is effective and may work as prevention for people who inject drugs. infohep news Treatment outcomes Risk of reinfection is a concern after successful hepatitis C treatment Liz Highleyman / 28 September 2016 People on opiate agonist substitution therapy can be successfully treated with grazoprevir/elbasvir (Zepatier) – achieving cure rates similar to those of the population as a whole – but some people are reinfected ... Treatment for people who use drugs HCV treatment is effective and may work as prevention for people who inject drugs Liz Highleyman / 19 September 2016 Hepatitis C treatment for people who inject drugs is as safe and effective as it is for non-drug-users – with cure rates exceeding 90% – and treating enough people in this population could ... Transmission and prevention Hepatitis C vaccine development shows progress but scientific barriers remain Liz Highleyman / 12 September 2016 An effective vaccine may be necessary to eliminate hepatitis C virus (HCV) but development has been hampered by several challenges including the variability of the virus and incomplete natural immunity, according to presentations ... Epidemiology INHSU 2016 opens with focus on hepatitis C prevention and treatment for people who inject drugs Liz Highleyman / 08 September 2016 The 5th International Symposium on Hepatitis Care in Substance Users (INHSU 2016) got underway yesterday with an overview of the epidemiology of hepatitis C virus (HCV) among people who inject drugs and ... Fatigue Effective antiviral treatment reduces fatigue in people with chronic hepatitis C Liz Highleyman / 08 September 2016 Fatigue – a common symptom among people living with hepatitis C virus (HCV) infection – is associated with liver inflammation and fibrosis, but antiviral therapy that leads to a cure significantly reduces ... View more > Editors' picks from other sources View more > Other pages in this section Latest news All the news Conference news Email bulletin archive